Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Development and validation of reassigned CEA, CYFRA21-1 and NSE-based models for lung cancer diagnosis and prognosis prediction

Fig. 2

Prognostic model for LC based on cp-score, age and stage. A and D ROC and corresponding AUCs for 12-month survival predicted by cp-score, age, stage and all combined in the training (A) and test (D) set. B and E Overall survival curves of patients with LC (both low and high risk of death) according to the combined prognosis score in the training set (B) and test set (E). C and F Calibration plot of nomogram for predicting 1-year overall survival in the training set (C) and test set (F). (G) Nomogram for predicting 1-, 2-, and 3-year overall survival of LC patients using TMs and other clinical factors. LC, lung cancer. TM, tumor marker. CEA, carcinoembryonic antigen. CYFRA21-1, cytokeratin-19 fragment. NSE, and neuron-specific enolase

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us